---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-014784"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T05:22:03.721922+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Hillstream BioPharma prices public offering of 5.3M shares at $0.50, raising $2.65M gross

## Summary
- Pricing of 5,300,000 shares at $0.50 each; underwriters granted 45-day option for 795,000 additional shares.
- Net proceeds ~$2.2M ($2.6M with full over-allotment); funds for HSB-1216, HSB-3215, HSB-1940 pipeline and working capital.
- Underwriting agreement with ThinkEquity as sole book-runner; Representative's Warrants for 3% of shares at $0.625.
- Offering expected close May 2, 2023; 90-day lock-up for company, 180-day for officers/directors.

## SEC filing metadata
- accession: 0001493152-23-014784
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000149315223014784/0001493152-23-014784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000149315223014784/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-014784
- JSON: https://secwatch.observer/filing/0001493152-23-014784.json
- Plain text: https://secwatch.observer/filing/0001493152-23-014784.txt

## Key facts
- Material Agreements
  Canton Strategic Holdings, Inc. entered into Underwriting Agreement with ThinkEquity LLC, as representative of the several underwriters listed on Schedule 1 thereto valued at approximately $2.2 million (effective 2023-04-27).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: ThinkEquity LLC, as representative of the several underwriters listed on Schedule 1 thereto
  - Value: approximately $2.2 million
  - Effective: 2023-04-27
  source text: On April 27, 2023 (the “Effective Date”), Hillstream BioPharma, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with ThinkEquity LLC (“ThinkEquity”), as representative of the several underwriters listed on Schedule 1 thereto (the “Underwriters”), relating to the public offering (the “Offering”) of 5,300,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a price to the public of $0.50 per Share (the “Offering Price”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861657/000149315223014784/0001493152-23-014784-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.